2.575USD-5.50%Mkt Cap: 377.65M USDP/E: —Last update: 2026-06-01
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap377.65M USD
Enterprise Value362.02M USD
Revenue (TTM)28.94M USD
Gross Profit18.36M USD
Net Income (TTM)-64.78M USD
Revenue/Share0.2430 USD
Last Price2.575 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees89
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.37
PEG—
EV/EBITDA-10.83
EV/Revenue12.51
P/S13.53
P/B1.49
EPS (TTM)-0.46
EPS (Forward)-0.32
52W Range
1.22086% of range2.790
52W High2.790 USD
52W Low1.220 USD
Profitability
Gross Margin98.38%
Oper. Margin-54.27%
EBITDA Margin-115.54%
Profit Margin-347.04%
ROE-24.26%
ROA-21.53%
Growth
Revenue Growth247.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-36.45M USD
CapEx (TTM)565.00K USD
FCF Margin-8.89%
FCF Yield-0.68%
Net Debt-29.40M USD
Net Debt/EBITDA0.88
Balance Sheet
Debt/Equity0.08
Current Ratio4.80
Quick Ratio4.55
Book Value/Sh1.814 USD
Cash/Share0.3380 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)7.333 USD
Target Range3.000 USD – 11.00 USD
# Analysts6
Ownership
Shares Out.144.97M
Float97.53M
Insiders15.24%
Institutions50.95%
Short Interest
Short Ratio5.5d
Short % Float3.73%
Short % Out.3.39%
Shares Short4.92M
Short (prev mo.)5.46M
Technical
SMA 501.741 (+47.9%)
SMA 2001.755 (+46.7%)
Beta0.62
S&P 52W Chg27.94%
Avg Vol (30d)870.95K
Avg Vol (10d)932.95K
Technical Indicators
RSI (14)80.1
MACD0.2923
MACD Signal0.2335
MACD Hist.+0.0588
BB Upper3.065 USD
BB Middle2.076 USD
BB Lower1.088 USD
BB Width95.22%
ATR (14)0.1437 USD
Vol Ratio (20d)0.23x